{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:32:53Z","timestamp":1791559973427,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["AdvG 2017-785809"],"award-info":[{"award-number":["AdvG 2017-785809"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.0C78.17N"],"award-info":[{"award-number":["G.0C78.17N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.0694.21N"],"award-info":[{"award-number":["G.0694.21N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","award":["METH14\/06"],"award-info":[{"award-number":["METH14\/06"]}],"id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Muscle weakness is a complication of critical illness which hampers recovery. In critically ill mice, supplementation with the ketone body 3-hydroxybutyrate has been shown to improve muscle force and to normalize illness-induced hypocholesterolemia. We hypothesized that altered cholesterol homeostasis is involved in development of critical illness-induced muscle weakness and that this pathway can be affected by 3-hydroxybutyrate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In both human critically ill patients and septic mice, the association between circulating cholesterol concentrations and muscle weakness was assessed. In septic mice, the impact of 3-hydroxybutyrate supplementation on cholesterol homeostasis was evaluated with use of tracer technology and through analysis of markers of cholesterol metabolism and downstream pathways.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum cholesterol concentrations were lower in weak than in non-weak critically ill patients, and in multivariable analysis adjusting for baseline risk factors, serum cholesterol was inversely correlated with weakness. In septic mice, plasma cholesterol correlated positively with muscle force. In septic mice, exogenous 3-hydroxybutyrate increased plasma cholesterol and altered cholesterol homeostasis, by normalization of plasma mevalonate and elevation of muscular, but not hepatic, expression of cholesterol synthesis genes. In septic mice, tracer technology revealed that 3-hydroxybutyrate was preferentially taken up by muscle and metabolized into cholesterol precursor mevalonate, rather than TCA metabolites. The 3-hydroxybutyrate protection against weakness was not related to ubiquinone or downstream myofiber mitochondrial function, whereas cholesterol content in myofibers was increased.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings point to a role for low cholesterol in critical illness-induced muscle weakness and to a protective mechanism-of-action for 3-hydroxybutyrate supplementation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-021-03688-1","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T10:02:28Z","timestamp":1626516148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate"],"prefix":"10.1186","volume":"25","author":[{"given":"Chlo\u00eb","family":"Goossens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Weckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Derde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Vander Perre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Derese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P.","family":"Van Veldhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Ghesqui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5320-1362","authenticated-orcid":false,"given":"Greet","family":"Van den Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-6809","authenticated-orcid":false,"given":"Lies","family":"Langouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,17]]},"reference":[{"issue":"4","key":"3688_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00134-020-05944-4","volume":"46","author":"I Vanhorebeek","year":"2020","unstructured":"Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637\u201353.","journal-title":"Intensive Care Med"},{"key":"3688_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13054-015-0993-7","volume":"19","author":"G Hermans","year":"2015","unstructured":"Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274.","journal-title":"Crit Care"},{"issue":"4","key":"3688_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1164\/rccm.201312-2257OC","volume":"190","author":"G Hermans","year":"2014","unstructured":"Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, Casaer MP, Meersseman P, Debaveye Y, Van Cromphaut S, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410\u201320.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3688_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.CCM.0000053651.38421.D9","volume":"31","author":"SN Fletcher","year":"2003","unstructured":"Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, Hinds CJ. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31(4):1012\u20136.","journal-title":"Crit Care Med"},{"issue":"1","key":"3688_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13054-019-2506-6","volume":"23","author":"C Goossens","year":"2019","unstructured":"Goossens C, Weckx R, Derde S, Dufour T, Vander Perre S, Pauwels L, Thiessen SE, Van Veldhoven PP, Van den Berghe G, Langouche L. Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones. Crit Care. 2019;23(1):236.","journal-title":"Crit Care"},{"issue":"1","key":"3688_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1210\/jc.2003-030760","volume":"89","author":"D Mesotten","year":"2004","unstructured":"Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab. 2004;89(1):219\u201326.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3688_CR7","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/00003246-200108000-00011","volume":"29","author":"BR Gordon","year":"2001","unstructured":"Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, Barie PS, Rubin AL. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med. 2001;29(8):1563\u20138.","journal-title":"Crit Care Med"},{"issue":"6","key":"3688_CR8","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/cc2382","volume":"7","author":"CM Dunham","year":"2003","unstructured":"Dunham CM, Fealk MH, Sever WE 3rd. Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Crit Care. 2003;7(6):R145-153.","journal-title":"Crit Care"},{"issue":"1","key":"3688_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13613-017-0284-3","volume":"7","author":"S Tanaka","year":"2017","unstructured":"Tanaka S, Labreuche J, Drumez E, Harrois A, Hamada S, Vigue B, Couret D, Duranteau J, Meilhac O. Low HDL levels in sepsis versus trauma patients in intensive care unit. Ann Intensive Care. 2017;7(1):60.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"3688_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ymgme.2012.08.017","volume":"107","author":"S Hasegawa","year":"2012","unstructured":"Hasegawa S, Noda K, Maeda A, Matsuoka M, Yamasaki M, Fukui T. Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels. Mol Genet Metab. 2012;107(3):553\u201360.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"3688_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0005-2760(81)90300-3","volume":"666","author":"JW Koper","year":"1981","unstructured":"Koper JW, Lopes-Cardozo M, Van Golde LM. Preferential utilization of ketone bodies for the synthesis of myelin cholesterol in vivo. Biochim Biophys Acta. 1981;666(3):411\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3688_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0014-5793(83)80833-3","volume":"163","author":"MJ Geelen","year":"1983","unstructured":"Geelen MJ, Lopes-Cardozo M, Edmond J. Acetoacetate: a major substrate for the synthesis of cholesterol and fatty acids by isolated rat hepatocytes. FEBS Lett. 1983;163(2):269\u201373.","journal-title":"FEBS Lett"},{"issue":"4","key":"3688_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0197-0186(85)90062-2","volume":"7","author":"M Lopes-Cardozo","year":"1985","unstructured":"Lopes-Cardozo M, Klein W. Contribution of acetoacetate to the synthesis of cholesterol and fatty acids in regions of developing rat brain in vivo. Neurochem Int. 1985;7(4):647\u201353.","journal-title":"Neurochem Int"},{"issue":"6","key":"3688_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1471-4159.1975.tb04428.x","volume":"25","author":"MS Patel","year":"1975","unstructured":"Patel MS, Johnson CA, Rajan R, Owen OE. The metabolism of ketone bodies in developing human brain: development of ketone-body-utilizing enzymes and ketone bodies as precursors for lipid synthesis. J Neurochem. 1975;25(6):905\u20138.","journal-title":"J Neurochem"},{"issue":"1","key":"3688_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","volume":"60","author":"AM Robinson","year":"1980","unstructured":"Robinson AM, Williamson DH. Physiological roles of ketone-bodies as substrates and signals in mammalian-tissues. Physiol Rev. 1980;60(1):143\u201387.","journal-title":"Physiol Rev"},{"issue":"17","key":"3688_CR16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgozoglu L, Nordestgaard BG, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015;36(17):1012\u201322.","journal-title":"Eur Heart J"},{"issue":"19","key":"3688_CR17","doi-asserted-by":"publisher","first-page":"e009835","DOI":"10.1161\/JAHA.118.009835","volume":"7","author":"H Qu","year":"2018","unstructured":"Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(19):e009835.","journal-title":"J Am Heart Assoc"},{"key":"3688_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fphys.2015.00105","volume":"6","author":"G Barrientos","year":"2015","unstructured":"Barrientos G, Llanos P, Hidalgo J, Bolanos P, Caputo C, Riquelme A, Sanchez G, Quest AF, Hidalgo C. Cholesterol removal from adult skeletal muscle impairs excitation-contraction coupling and aging reduces caveolin-3 and alters the expression of other triadic proteins. Front Physiol. 2015;6:105.","journal-title":"Front Physiol"},{"issue":"5\u20136","key":"3688_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1159\/000186933","volume":"29","author":"J Vega-Moreno","year":"2012","unstructured":"Vega-Moreno J, Tirado-Cortes A, Alvarez R, Irles C, Mas-Oliva J, Ortega A. Cholesterol depletion uncouples beta-dystroglycans from discrete sarcolemmal domains, reducing the mechanical activity of skeletal muscle. Cell Physiol Biochem. 2012;29(5\u20136):905\u201318.","journal-title":"Cell Physiol Biochem"},{"issue":"Pt 1","key":"3688_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1469-7793.2001.00071.x","volume":"534","author":"BS Launikonis","year":"2001","unstructured":"Launikonis BS, Stephenson DG. Effects of membrane cholesterol manipulation on excitation-contraction coupling in skeletal muscle of the toad. J Physiol. 2001;534(Pt 1):71\u201385.","journal-title":"J Physiol"},{"issue":"2","key":"3688_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1042\/bj1680229","volume":"168","author":"TA de Kretser","year":"1977","unstructured":"de Kretser TA, Livett BG. Skeletal-muscle sarcolemma from normal and dystrophic mice. Isolation, characterization and lipid composition. Biochem J. 1977;168(2):229\u201337.","journal-title":"Biochem J"},{"key":"3688_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mri.2017.01.001","volume":"38","author":"NK Srivastava","year":"2017","unstructured":"Srivastava NK, Yadav R, Mukherjee S, Pal L, Sinha N. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease. Magn Reson Imaging. 2017;38:163\u201373.","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"3688_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1056\/NEJMoa1102662","volume":"365","author":"MP Casaer","year":"2011","unstructured":"Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365(6):506\u201317.","journal-title":"N Engl J Med"},{"issue":"8","key":"3688_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S2213-2600(13)70183-8","volume":"1","author":"G Hermans","year":"2013","unstructured":"Hermans G, Casaer MP, Clerckx B, Guiza F, Vanhullebusch T, Derde S, Meersseman P, Derese I, Mesotten D, Wouters PJ, et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med. 2013;1(8):621\u20139.","journal-title":"Lancet Respir Med"},{"key":"3688_CR25","doi-asserted-by":"crossref","unstructured":"Derde S, Thiessen S, Goossens C, Dufour T, Van den Berghe G, Langouche L. Use of a central venous line for fluids, drugs and nutrient administration in a mouse model of critical illness. Jove-J Vis Exp. 2017;123:e55553.","DOI":"10.3791\/55553"},{"issue":"5","key":"3688_CR26","doi-asserted-by":"publisher","first-page":"R245","DOI":"10.1186\/cc10503","volume":"15","author":"L Langouche","year":"2011","unstructured":"Langouche L, Marques MB, Ingels C, Gunst J, Derde S, Vander Perre S, D\u2019Hoore A, Van den Berghe G. Critical illness induces alternative activation of M2 macrophages in adipose tissue. Crit Care. 2011;15(5):R245.","journal-title":"Crit Care"},{"issue":"1","key":"3688_CR27","doi-asserted-by":"publisher","first-page":"14150","DOI":"10.1038\/s41598-017-14405-w","volume":"7","author":"SE Thiessen","year":"2017","unstructured":"Thiessen SE, Derese I, Derde S, Dufour T, Pauwels L, Bekhuis Y, Pintelon I, Martinet W, Van den Berghe G, Vanhorebeek I. The role of autophagy in critical illness-induced liver damage. Sci Rep. 2017;7(1):14150.","journal-title":"Sci Rep"},{"issue":"1","key":"3688_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1006\/abio.1998.2584","volume":"258","author":"PP Van Veldhoven","year":"1998","unstructured":"Van Veldhoven PP, Meyhi E, Mannaerts GP. Enzymatic quantitation of cholesterol esters in lipid extracts. Anal Biochem. 1998;258(1):152\u20135.","journal-title":"Anal Biochem"},{"issue":"Pt 3","key":"3688_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1258\/acb.2010.010182","volume":"48","author":"J Waldron","year":"2011","unstructured":"Waldron J, Webster C. Liquid chromatography-tandem mass spectrometry method for the measurement of serum mevalonic acid: a novel marker of hydroxymethylglutaryl coenzyme A reductase inhibition by statins. Ann Clin Biochem. 2011;48(Pt 3):223\u201332.","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"3688_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1172\/JCI111495","volume":"74","author":"TS Parker","year":"1984","unstructured":"Parker TS, McNamara DJ, Brown CD, Kolb R, Ahrens EH Jr, Alberts AW, Tobert J, Chen J, De Schepper PJ. Plasma mevalonate as a measure of cholesterol synthesis in man. J Clin Invest. 1984;74(3):795\u2013804.","journal-title":"J Clin Invest"},{"issue":"5","key":"3688_CR31","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1128\/IAI.69.5.2821-2828.2001","volume":"69","author":"JH Levels","year":"2001","unstructured":"Levels JH, Abraham PR, van den Ende A, van Deventer SJ. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun. 2001;69(5):2821\u20138.","journal-title":"Infect Immun"},{"issue":"9","key":"3688_CR32","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1016\/S0021-9258(20)81980-2","volume":"258","author":"S Bhakdi","year":"1983","unstructured":"Bhakdi S, Tranum-Jensen J, Utermann G, Fussle R. Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein. J Biol Chem. 1983;258(9):5899\u2013904.","journal-title":"J Biol Chem"},{"issue":"1","key":"3688_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1128\/iai.63.1.253-258.1995","volume":"63","author":"TS Parker","year":"1995","unstructured":"Parker TS, Levine DM, Chang JC, Laxer J, Coffin CC, Rubin AL. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun. 1995;63(1):253\u20138.","journal-title":"Infect Immun"},{"key":"3688_CR34","doi-asserted-by":"crossref","unstructured":"Marik PE. Adrenal insufficiency: the link between low apolipoprotein A-I levels and poor outcome in the critically ill? Crit Care Med. 2004; 32(9):1977\u20131978; author reply 1978\u20131979.","DOI":"10.1097\/01.CCM.0000132895.89019.32"},{"issue":"12","key":"3688_CR35","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00134-003-2021-7","volume":"29","author":"PHJ van der Voort","year":"2003","unstructured":"van der Voort PHJ, Gerritsen RT, Bakker AJ, Boerma EC, Kuiper MA, de Heide L. HDL-cholesterol level and cortisol response to synacthen in critically ill patients. Intensive Care Med. 2003;29(12):2199\u2013203.","journal-title":"Intensive Care Med"},{"issue":"4","key":"3688_CR36","doi-asserted-by":"publisher","first-page":"R189","DOI":"10.1186\/cc10343","volume":"15","author":"MW Donnino","year":"2011","unstructured":"Donnino MW, Cocchi MN, Salciccioli JD, Kim D, Naini AB, Buettner C, Akuthota P. Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock. Crit Care. 2011;15(4):R189.","journal-title":"Crit Care"},{"issue":"9328","key":"3688_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","volume":"360","author":"D Brealey","year":"2002","unstructured":"Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219\u201323.","journal-title":"Lancet"},{"issue":"7","key":"3688_CR38","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/jama.290.7.912","volume":"290","author":"PO Kwiterovich Jr","year":"2003","unstructured":"Kwiterovich PO Jr, Vining EP, Pyzik P, Skolasky R Jr, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 2003;290(7):912\u201320.","journal-title":"JAMA"},{"issue":"1","key":"3688_CR39","doi-asserted-by":"publisher","first-page":"e000429","DOI":"10.1136\/bmjsem-2018-000429","volume":"4","author":"BC Creighton","year":"2018","unstructured":"Creighton BC, Hyde PN, Maresh CM, Kraemer WJ, Phinney SD, Volek JS. Paradox of hypercholesterolaemia in highly trained, keto-adapted athletes. BMJ Open Sport Exerc Med. 2018;4(1):e000429.","journal-title":"BMJ Open Sport Exerc Med"},{"key":"3688_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12986-016-0069-y","volume":"13","author":"SL Kesl","year":"2016","unstructured":"Kesl SL, Poff AM, Ward NP, Fiorelli TN, Ari C, Van Putten AJ, Sherwood JW, Arnold P, D\u2019Agostino DP. Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats. Nutr Metab (Lond). 2016;13:9.","journal-title":"Nutr Metab (Lond)"},{"issue":"12","key":"3688_CR41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s11745-015-4085-x","volume":"50","author":"MF Kemper","year":"2015","unstructured":"Kemper MF, Srivastava S, Todd King M, Clarke K, Veech RL, Pawlosky RJ. An ester of beta-hydroxybutyrate regulates cholesterol biosynthesis in rats and a cholesterol biomarker in humans. Lipids. 2015;50(12):1185\u201393.","journal-title":"Lipids"},{"issue":"15","key":"3688_CR42","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1016\/S0021-9258(19)63335-1","volume":"252","author":"RJ Webber","year":"1977","unstructured":"Webber RJ, Edmond J. Utilization of L(+)-3-hydroxybutyrate, D(-)-3-hydroxybutyrate, acetoacetate, and glucose for respiration and lipid synthesis in the 18-day-old rat. J Biol Chem. 1977;252(15):5222\u20136.","journal-title":"J Biol Chem"},{"issue":"14","key":"3688_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320(14):1455\u201363.","journal-title":"JAMA"},{"issue":"11","key":"3688_CR44","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1097\/CCM.0b013e3181b0266c","volume":"37","author":"RP Dellinger","year":"2009","unstructured":"Dellinger RP, Tomayko JF, Angus DC, Opal S, Cupo MA, McDermott S, Ducher A, Calandra T, Cohen J, Lipid I, et al. Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial. Crit Care Med. 2009;37(11):2929\u201338.","journal-title":"Crit Care Med"},{"key":"3688_CR45","doi-asserted-by":"crossref","unstructured":"Guirgis FW, Black LP, Rosenthal MD, Henson M, Ferreira J, Leeuwenburgh C, Kalynych C, Moldawer LL, Miller T, Jones L, et al. LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I\/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock. BMJ Open 2019; 9(9):e029348.","DOI":"10.1136\/bmjopen-2019-029348"},{"issue":"7","key":"3688_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1164\/rccm.201512-2344OC","volume":"194","author":"C Dos Santos","year":"2016","unstructured":"Dos Santos C, Hussain SN, Mathur S, Picard M, Herridge M, Correa J, Bain A, Guo Y, Advani A, Advani SL, et al. Mechanisms of chronic muscle wasting and dysfunction after an intensive care unit stay. A pilot study. Am J Respir Crit Care Med. 2016;194(7):821\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3688_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1194\/jlr.M019927","volume":"53","author":"W Yin","year":"2012","unstructured":"Yin W, Carballo-Jane E, McLaren DG, Mendoza VH, Gagen K, Geoghagen NS, McNamara LA, Gorski JN, Eiermann GJ, Petrov A, et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res. 2012;53(1):51\u201365.","journal-title":"J Lipid Res"},{"issue":"9","key":"3688_CR48","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.120.048568","volume":"143","author":"M Trinder","year":"2021","unstructured":"Trinder M, Wang Y, Madsen CM, Ponomarev T, Bohunek L, Daisely BA, Julia Kong H, Blauw LL, Nordestgaard BG, Tybjaerg-Hansen A, et al. Inhibition of cholesteryl ester transfer protein preserves high-density lipoprotein cholesterol and improves survival in sepsis. Circulation. 2021;143(9):921\u201334.","journal-title":"Circulation"},{"key":"3688_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fcvm.2019.00046","volume":"6","author":"S Oppi","year":"2019","unstructured":"Oppi S, Luscher TF, Stein S. Mouse models for atherosclerosis research-which is my line? Front Cardiovasc Med. 2019;6:46.","journal-title":"Front Cardiovasc Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-021-03688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T17:08:23Z","timestamp":1629220103000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-021-03688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3688"],"URL":"https:\/\/doi.org\/10.1186\/s13054-021-03688-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,17]]},"assertion":[{"value":"4 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Ethical Committee for Animal Experimentation of the KU Leuven had approved the protocols for these animal studies (internal project numbers p009\/2016, p124\/2017, p032\/2018). The study protocol of the human studies had been approved by the Institutional Review Board of the KU Leuven (ML4190). Written informed consent was obtained from the patients' closest family member and from healthy volunteers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that there is no conflict of interest to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}